Meet the investigator: Daniel D. Billadeau, Ph.D.
At the Mayo Clinic Cancer Center, hundreds of researchers dedicate their professional lives to reducing the burden of cancer. Each one has a unique story. In this issue, Daniel D. Billadeau, Ph.D., an oncology researcher at Mayo Clinic in Rochester, Minnesota, talks about his work investigating pancreatic cancer. Dr. Billadeau is also a principal investigator of the Mayo Clinic Pancreatic Cancer SPORE.
This article was originally published in Forefront, Mayo Clinic Cancer Center's online magazine, which ceased publication in December 2020.
Researchers demonstrated a way to predict survival outcomes for people with borderline resectable or locally advanced pancreatic cancer.
Vishakha Majithia's story of pancreatic cancer treatment at Mayo Clinic and surviving to hold her first grandchild.
Dr. Mark Truty explains the risk factors and symptoms of pancreatic cancer and how it is diagnosed and treated.